An improved understanding of chronic graft-versus-host disease (cGVHD) and its pathogenesis has led to the development of novel treatments. Future ......READ MORE
Clinicians employ multiple strategies to prevent and treat acute and chronic graft-versus-host disease (aGVHD and cGVHD, respectively). Selective T......READ MORE
by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and Edmund K. Waller, MD, PhD, FACP
As the underlying pathways involved in chronic graft-versus-host disease (cGVHD) are becoming better understood, novel therapies targeting these pa......READ MORE
by Corey Cutler, MD, MPH, FRCPC; David Miklos, MD, PhD; and Edmund K. Waller, MD, PhD, FACP
The treatment of chronic graft-versus-host disease (cGVHD) now includes novel systemic therapies in addition to established agents such as corticos......READ MORE
Chronic graft-versus-host disease (cGVHD) may have some atypical manifestations that have not classically been ascribed to the disease. Efforts to ......READ MORE
Chronic graft-versus-host disease (cGVHD) involves both inflammatory and fibrotic pathologies. While most treatments for cGVHD target the inflammat......READ MORE
